Targetome
2010
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Grant
LATEST DEAL TYPE
$998K
LATEST DEAL AMOUNT
5
INVESTORS
Description
Developer of affinity-based targeted therapies intended to be used for the diagnosis of cancer. The company's therapies works with the help of a biomarker discovery platform, enabling healthcare professionals to get the treatment of pancreatic cancer or liver metastases along with getting services related to the identification and validation of proteomic biomarkers and biologics generation, for the therapeutic or diagnostic purpose.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Services
Primary Office
- GIGA EE1 Tower
- Avenue Hippocrate 5
- 4000 Liège
- Belgium
+32 04 000 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Targetome’s full profile, request a free trial.
Targetome Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 29-Feb-2016 | $998K | 00.000 | Completed | Generating Revenue | |
| 3. Early Stage VC | 09-Oct-2015 | 00000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 2. Early Stage VC | 26-Jul-2013 | $1.08M | $1.08M | 00.000 | Completed | Startup |
| 1. Accelerator/Incubator | 01-Sep-2011 | Completed | Startup |
Targetome Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Class G | 0,000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | ||
| Class F | 000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | ||
| Class C | 000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | ||
| Preference | 2,252 | $336.88 | $336.88 | 1x | $336.88 | 40.02% | ||
| Preference | 500 | $336.88 | $336.88 | 1x | $336.88 | 8.89% |
Targetome Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Walloon Region | Lender/Debt Provider | 000 0000 | 000000 0 | |||
| Medical Research Council Technology | Corporation | Minority | 000 0000 | 000000 0 | ||
| Gesval | Lender/Debt Provider | Minority | 000 0000 | 000000 0 | ||
| Noshaq | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| WBC | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
Targetome Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Vincent Castronovo | Founder |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »